CVRx Inc (CVRX)

Name: CVRx Inc (CVRX) Share Price Today, Stock Analysis, Annual Report | Value Research
Brand: CVRx Inc (CVRX)

Stock Card

$2.95

$-0.09 (-2.96%)

As on 28-Aug-2026 16:00EDT

Market cap

$79 Mln

Revenue (TTM)

$61 Mln

P/E Ratio

P/B Ratio

Div. Yield

0 %

CVRx Inc (CVRX) Share Price

Compare

High: Low: Return:

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 2.94 High: 3.15

52 Week Range

Low: 2.20 High: 11.30

Liquidity

Low Moderate High

Fundamentals

Net Profit (TTM)

$0 Mln
ROE

-1.3 %
ROCE

-- %
Industry P/E

44.46
EV/EBITDA

-1.3
Debt to Equity

2.9
Book Value

$0.7
EPS

$-2
Face value

--
Shares outstanding

26,641,597

5 Years Aggregate

CFO

$-138.31 Mln

EBITDA

$-149.29 Mln

Net Profit

$-154.45 Mln

Company	YTD	1 Month	3 Months	1 Year	3 Years	5 Years	10 Years
CVRx Inc (CVRX)	-58.5	-39.5	-49.0	-61.0	-44.6	-31.1	--
BSE Sensex^*	-8.6	-0.7	3.5	-3.0	5.9	6.4	10.6
S&P Small-Cap 600^#	-5.8	-5.3	-13.7	-6.3	5.3	3.0	5.5

As on 28-Aug-2026 | *As on 31-Aug-2026 | #As on 26-Oct-2023

Company	2025	2024	2023	2022
CVRx Inc (CVRX)	-44.0	-59.4	71.3	50.0
S&P Small-Cap 600	4.0	7.0	13.9	-17.4
BSE Sensex	9.1	8.1	18.7	4.4

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

Key Ratios

View Details

Peers

View Details

Company	Price ($)	Market Cap ($ Mln)	Revenue (TTM)	Net Profit (TTM)	OPM (%)	ROE (%)	P/E	P/B
CVRx Inc (CVRX)	3.0	78.6	61.2	-52.0	-75.1	-175.3	--	4.0
10X Genomics Inc (TXG)	61.5	8,018.1	616.9	-75.1	1.7	-9.3	--	10.2
Avantor (AVTR)	14.6	9,638.1	6,561.1	-578.0	-4.5	-10.3	--	1.7
Bio-Rad Laboratories	365.1	9,761.6	2,589.3	222.4	-6.0	3	44.5	1.3
Bruker (BRKR)	57.1	8,696.7	3,499.6	-71.2	0.5	-3.2	--	3.8
Glaukos Corp (GKOS)	179.9	10,905.5	612.8	-188.1	-30.6	-28.1	--	16.4
Lantheus Holdings (LNTH)	100.8	6,577.5	1,556.3	275.3	24.6	22.9	24.1	5.0
Penumbra (PEN)	321.7	12,752.7	1,504.9	160.6	13.6	10.9	79.4	8.4
Repligen (RGEN)	176.3	9,947.9	785.1	41.5	9.9	2	251.8	4.9
Smith & Nephew SNATS - ADR	29.0	12,153.4	6,164.0	625.0	13.0	11.8	19.9	2.4

Shareholding Pattern

View Details

About CVRx Inc (CVRX)

CVRx, Inc., a commercial-stage medical device company, engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases in the United States, Germany, and internationally. The company... offers Barostim, an implantable device that delivers electrical pulses to baroreceptors located in the wall of the carotid artery to counteract decreased baroreceptor signaling, and provides baroreflex activation therapy, which links the cardiovascular system to the autonomic nervous system. It sells its products through direct sales force, sales agents, and independent distributors. The company was incorporated in 2000 and is headquartered in Minneapolis, Minnesota. Read more

President, CEO & Director

Mr. Kevin Hykes
President, CEO & Director

Mr. Kevin Hykes
Headquarters

Minneapolis, MN
Website

https://www.barostim.com

FAQs for CVRx Inc (CVRX)

What is the current share price of CVRx Inc (CVRX) Today?

The share price of CVRx Inc (CVRX) is $2.95 (NASDAQ) as of 28-Aug-2026 16:00 EDT. CVRx Inc (CVRX) has given a return of -44.56% in the last 3 years.

What is the current PB & PE ratio of CVRx Inc (CVRX)?

Since, TTM earnings of CVRx Inc (CVRX) is negative, P/E ratio is not available.
The P/B ratio of CVRx Inc (CVRX) is 4.05 times as on 28-Aug-2026, a 7 premium to its peers’ median range of 3.79 times.

PE & PB ratio at the end of financial year.